Advertisement

Ads Placeholder
Loading...

GSK plc

GSK•NYSE
Healthcare
Drug Manufacturers - General
$56.69
$0.70(1.25%)
U.S. Market opens in NaNh NaNm

GSK plc (GSK) Stock Overview

Explore GSK plc’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap114.2B
P/E Ratio15.11
EPS (TTM)$3.68
ROE0.30%
Fundamental Analysis

AI Price Forecasts

1 Month$51.13
3 Months$71.27
1 Year Target$52.87

GSK Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of GSK plc (GSK) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 60.19, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $52.87.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 15.11 and a market capitalization of 114.2B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
1.25%
5-Day Change
4.54%
1-Month Change
-0.67%
3-Month Change
14.23%
6-Month Change
30.77%
Year-to-Date (YTD) Change
14.23%
1-Year Change
45.32%
3-Year Change
57.69%
5-Year Change
57.12%
All-Time (Max) Change
8538.48%

Contact Information

https://www.gsk.com
44 20 8047 5000
980 Great West Road, Brentford, NaN, TW8 9GS

Company Facts

686,290 Employees
IPO DateMar 28, 1980
CountryGB
Actively Trading

Frequently Asked Questions